Oxidative stress in systemic lupus erythematous: comment on the article by Wang et al

Comment

C Michael Stein. Arthritis Rheum. 2010 Dec.

. 2010 Dec;62(12):3835-6.

doi: 10.1002/art.27719.

No abstract available

Comment on

Markers of oxidative and nitrosative stress in systemic lupus erythematosus: correlation with disease activity.
Wang G, Pierangeli SS, Papalardo E, Ansari GA, Khan MF. Wang G, et al. Arthritis Rheum. 2010 Jul;62(7):2064-72. doi: 10.1002/art.27442. Arthritis Rheum. 2010. PMID: 20201076 Free PMC article.

Characterization of flares in patients with systemic lupus erythematosus: comment on the article by Ho et al.
Ayoub N, Ayoub G, Rouphael N. Ayoub N, et al. Arthritis Rheum. 2003 Feb;48(2):581-2; author reply 582. doi: 10.1002/art.10644. Arthritis Rheum. 2003. PMID: 12571875 No abstract available.
8-Isoprostaglandin F2 alpha: a potential index of lipid peroxidation in systemic lupus erythematosus.
Abou-Raya A, el-Hallous D, Fayed H. Abou-Raya A, et al. Clin Invest Med. 2004 Dec;27(6):306-11. Clin Invest Med. 2004. PMID: 15675110
Premature coronary disease in systemic lupus.
Violi F, Loffredo L, Ferro D. Violi F, et al. N Engl J Med. 2004 Apr 8;350(15):1571-5; author reply 1571-5. N Engl J Med. 2004. PMID: 15074010 No abstract available.
F2-isoprostanes as markers of oxidative stress in vivo: an overview.
Milne GL, Musiek ES, Morrow JD. Milne GL, et al. Biomarkers. 2005 Nov;10 Suppl 1:S10-23. doi: 10.1080/13547500500216546. Biomarkers. 2005. PMID: 16298907 Review.
Potential role of isoketals formed via the isoprostane pathway of lipid peroxidation in ischemic arrhythmias.
Boyden PA, Davies SS, Viswanathan PC, Amarnath V, Balser JR, Roberts LJ 2nd. Boyden PA, et al. J Cardiovasc Pharmacol. 2007 Nov;50(5):480-6. doi: 10.1097/FJC.0b013e31815a0564. J Cardiovasc Pharmacol. 2007. PMID: 18030056 Review.